These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2961055)

  • 1. Clinical aspects of skin reactions to NSAIDs.
    Roujeau JC
    Scand J Rheumatol Suppl; 1987; 65():131-4. PubMed ID: 2961055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse drug reactions and organ damage: The skin.
    Marzano AV; Borghi A; Cugno M
    Eur J Intern Med; 2016 Mar; 28():17-24. PubMed ID: 26674736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug eruptions caused by noncorticoid anti-inflammatory agents].
    Roujeau JC; Guillaume JC; Revuz J; Touraine R
    Ann Med Interne (Paris); 1984; 135(8):633-6. PubMed ID: 6241438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England.
    Layton D; Marshall V; Boshier A; Friedmann P; Shakir SA
    Drug Saf; 2006; 29(8):687-96. PubMed ID: 16872242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stevens Johnson syndrome, toxic epidermal necrolysis and SJS-TEN overlap: a retrospective study of causative drugs and clinical outcome.
    Sharma VK; Sethuraman G; Minz A
    Indian J Dermatol Venereol Leprol; 2008; 74(3):238-40. PubMed ID: 18583791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Harr T; French LE
    Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: A review of the literature.
    Ward KE; Archambault R; Mersfelder TL
    Am J Health Syst Pharm; 2010 Feb; 67(3):206-13. PubMed ID: 20101062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in northeastern Malaysia.
    Kamaliah MD; Zainal D; Mokhtar N; Nazmi N
    Int J Dermatol; 1998 Jul; 37(7):520-3. PubMed ID: 9679693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
    Tan SK; Tay YK
    Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
    Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
    J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients.
    Chan HL; Stern RS; Arndt KA; Langlois J; Jick SS; Jick H; Walker AM
    Arch Dermatol; 1990 Jan; 126(1):43-7. PubMed ID: 2404462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical study of cutaneous drug eruptions in 200 patients.
    Raksha MP; Marfatia YS
    Indian J Dermatol Venereol Leprol; 2008; 74(1):80. PubMed ID: 18193504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
    Choon SE; Lai NM
    Indian J Dermatol Venereol Leprol; 2012; 78(6):734-9. PubMed ID: 23075643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Wolkenstein P; Chosidow O; Fléchet ML; Robbiola O; Paul M; Dumé L; Revuz J; Roujeau JC
    Contact Dermatitis; 1996 Oct; 35(4):234-6. PubMed ID: 8957644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
    Ding WY; Lee CK; Choon SE
    Int J Dermatol; 2010 Jul; 49(7):834-41. PubMed ID: 20618508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bullous fixed drug eruption masquerading as recurrent Stevens Johnson syndrome.
    Dharamsi FM; Michener MD; Dharamsi JW
    J Emerg Med; 2015 May; 48(5):551-4. PubMed ID: 25433836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum IL-17 in patients with erythema multiforme or Stevens-Johnson syndrome/toxic epidermal necrolysis drug reaction, and correlation with disease severity.
    Morsy H; Taha EA; Nigm DA; Shahin R; Youssef EMK
    Clin Exp Dermatol; 2017 Dec; 42(8):868-873. PubMed ID: 28940568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of mucocutaneous reactions in children treated with niflumic acid, other nonsteroidal antiinflammatory drugs, or nonopioid analgesics.
    Sturkenboom M; Nicolosi A; Cantarutti L; Mannino S; Picelli G; Scamarcia A; Giaquinto C;
    Pediatrics; 2005 Jul; 116(1):e26-33. PubMed ID: 15930187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting Lesional Granulysin Levels for Rapid Diagnosis of Cytotoxic T lymphocyte-Mediated Bullous Skin Disorders.
    Chen CB; Kuo KL; Wang CW; Lu CW; Chung-Yee Hui R; Lu KL; Chang WC; Chen WT; Yun F; Teng YC; Lee HE; Lin JY; Ho HC; Chi MH; Yu-Wei Lin Y; Chang CJ; Lin Y; Ku CL; Hung SI; Chang YC; Chung WH;
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1327-1337.e3. PubMed ID: 33039642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical study of cutaneous drug eruptions in 200 patients.
    Patel RM; Marfatia YS
    Indian J Dermatol Venereol Leprol; 2008; 74(4):430. PubMed ID: 18810845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.